@misc{indiciae40a97b25fe2a,
  title = {Targeting CD19-positive lymphomas with the antibody-drug conjugate (ADC) loncastuximab tesirine: preclinical evidence as single agent and as combinatorial approach},
  author = {Tarantelli, C. and Wald, D. and Munz, N. and Spriano, F. and Bruscaggin, A. and Cannas, E. and Cascione, L. and Gaudio, E. and Arribas, A. J. and Manjappa, S. and Golino, G. and Scalise, L. and Zucca, E. and Stathis, A. and Van Berkel, P. H. and Rossi, D. and Caimi, P. F. and Zammarchi, F. and Bertoni, F.},
  year = {2023},
  doi = {10.1101/2023.08.17.553668},
  url = {https://www.biorxiv.org/content/10.1101/2023.08.17.553668v1},
  note = {Source identifier: 10.1101/2023.08.17.553668}
}